Deutsch   English   Français   Italiano  
<HrXKN.15839763$ee1.6181350@fx16.ams4>

View for Bookmarking (what is this?)
Look up another Usenet article

Path: ...!news-out.netnews.com!news.alt.net!us1.netnews.com!weretis.net!feeder6.news.weretis.net!usenet.blueworldhosting.com!diablo1.usenet.blueworldhosting.com!peer03.iad!feed-me.highwinds-media.com!peer03.ams4!peer.am4.highwinds-media.com!news.highwinds-media.com!fx16.ams4.POSTED!not-for-mail
MIME-Version: 1.0
User-Agent: Mozilla Thunderbird
Subject: =?UTF-8?Q?Re=3A_Pr=C3=A9occupations_concernant_les_transfusions_de_?=
 =?UTF-8?Q?produits_sanguins_d=C3=A9riv=C3=A9es_des_receveurs_de_vaccins_g?=
 =?UTF-8?Q?=C3=A9niques?=
Content-Language: fr
Newsgroups: fr.bio.medecine
References: <VRDKN.15773249$ee1.3013026@fx16.ams4>
 <W9vfl7Ih_9PIro6QvD3-PzwYWZM@jntp>
From: Paul Aubrin <paul.aubrin@invalid.org>
In-Reply-To: <W9vfl7Ih_9PIro6QvD3-PzwYWZM@jntp>
Content-Type: text/plain; charset=UTF-8; format=flowed
Content-Transfer-Encoding: 8bit
Lines: 32
Message-ID: <HrXKN.15839763$ee1.6181350@fx16.ams4>
X-Complaints-To: abuse@eweka.nl
NNTP-Posting-Date: Thu, 21 Mar 2024 14:25:43 UTC
Organization: Eweka Internet Services
Date: Thu, 21 Mar 2024 15:25:43 +0100
X-Received-Bytes: 2600
Bytes: 2821

Le 20/03/2024 à 18:45, Duzz' a écrit :
> Le 20/03/2024 à 17:08, Paul Aubrin a écrit :
>>
>> https://doi.org/10.20944/preprints202403.0881.v1
> 
> Arnaque déjà tentée par le troll microcéphale Jap.
> MDPI + Preprint => Poubelle
Il n'est pire sourd que celui qui refuse d'entendre.

Faute de pouvoir contester le message, Duzz attaque le messager. 
Classique de la part d'un troll tel que Duzz.

Le papier (21 pages) est ici :
file:///home/jpm/T%C3%A9l%C3%A9chargements/preprints202403.0881.v1.pdf
7. Conclusion
Finally, we would like to state that if we continue to use genetic 
vaccines such as pseudouridinated mRNAs and mRNA-LNP platforms [46,103], 
there will be further risks like those described in this review. It 
should also be stressed that the issues discussed here are matters that
pertain to all organ transplants, including bone marrow transplants, and 
not just blood products. The impact of these genetic vaccines on blood 
products and the actual damage caused by them are
unknown at present. Therefore, in order to avoid these risks and prevent 
further expansion of blood contamination and complication of the 
situation, we strongly request that the vaccination campaign
using genetic vaccines be suspended and that a harm–benefit assessment 
be carried out as early as possible, as called for by Fraiman et al. and 
Polykretis et al. [27,31–33]. As we have repeatedly stated,
the health injuries caused by genetic vaccination are already extremely 
serious, and it is high time that countries and relevant organizations 
take concrete steps together to identify the risks and to control and 
resolve them.